Effect of Paclitaxel ± Bevacizumab on PFS Rate Among Patients With Relapsed Ovarian Sex Cord–Stromal Tumors
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
JAMA Oncology